Vascular endothelial growth factor and its type 2 receptor in tumors and serum of patients with renal cancerстатья
Информация о цитировании статьи получена из
Web of Science ,
Scopus
Статья опубликована в журнале из списка Web of Science и/или Scopus
Дата последнего поиска статьи во внешних источниках: 23 сентября 2021 г.
Авторы:
Kushlinsky N.E. ,
Trapeznikova M.F. ,
Gershtein E.S. ,
Glibin P.A.,
Kazantceva I.A. ,
Kilichbekov M.B.
Журнал:
Bulletin of Experimental Biology and Medicine
Том:
145
Номер:
6
Год издания:
2008
Издательство:
Springer Nature
Местоположение издательства:
Switzerland
Первая страница:
744
Последняя страница:
747
DOI:
10.1007/s10517-008-0188-1
Аннотация:
It was found that renal cancer tissue is characterized by increased content of VEGF not depending on the parameters of normal tissue and expression of VEGFR2 receptor. At the same time, the content of VEGFR2 in the tumor is determined by the state of the surrounding tissue and increases in low number of patients with tumors invading the renal capsule. Serum concentrations of VEGF and VEGFR2 in patients with renal cancer did not significantly differ from the corresponding values in the control group. No significant correlations between the levels of VEGF and VEGFR2 in the blood and tumor tissue were found. В© Springer Science+Business Media, Inc. 2008.
Добавил в систему:
Герштейн Елена Сергеевна